ProShares Bitcoin ETF vs Inovio Pharmaceuticals Inc — how do they compare? ProShares Bitcoin ETF trades at $8.66, while Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M). Which is the better fit depends on your goals.
| BITO | INO | |
|---|---|---|
Sector | Crypto-linked | Health |
52-Week High | $22.27 | $2.87 |
52-Week Low | $7.98 | $0.66 |
Market Cap | — | $78.55M |
Enterprise Value | — | $49.56M |
Trailing returns across standard periods
BITO offers exposure to Bitcoin returns primarily through Bitcoin futures contracts. It provides a regulated way for investors to trade Bitcoin performance within a traditional brokerage account without direct ownership.
Read more on BITO →Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →